Last reviewed: June 5, 2026
Last updated: June 5, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.
GLP-1 receptor agonists like semaglutide and tirzepatide reduce appetite and improve blood sugar control, but meaningful progress extends beyond weight alone. Clinical trials show patients on tirzepatide lose 15-22% of body weight over 68 weeks, yet many overlook the metabolic and behavioral improvements happening simultaneously.
Weekly Weight and Measurement Tracking for GLP-1 Users
Weight loss on semaglutide or tirzepatide is typically gradual and steady rather than dramatic week-to-week. Most patients begin noticing measurable changes between weeks 2-4, with consistent loss accelerating as dose adjusts upward. Weighing yourself weekly at the same time of day and recording the result creates a reliable baseline; daily weigh-ins often introduce noise from hydration and digestion cycles.
Beyond the scale, body measurements provide insight into fat loss versus muscle preservation. Track waist circumference at the narrowest point, hip measurement at the widest point, and chest measurement across the fullest area. Many PlexusDx patients report losing inches before significant weight drops appear, signaling metabolic shifts even when the scale moves slowly.
Fit and comfort in clothing serve as practical progress markers that many patients overlook. Notching a belt tighter, needing smaller jeans, or finding previous workout gear loose often occurs before the scale reflects substantial change, making clothing fit a valid—and emotionally rewarding—tracking method.
Monitoring Metabolic Markers and Blood Sugar Response
GLP-1 medications improve fasting glucose, HbA1c (three-month average blood sugar), and insulin sensitivity independent of weight loss alone. Request baseline bloodwork before starting tirzepatide or semaglutide, then recheck fasting glucose and HbA1c at 6-8 weeks, then at 3 and 6 months. A drop in HbA1c of 1-2 percentage points signals that your pancreas is producing less insulin and your cells are responding better to the hormone present.
Triglycerides and LDL cholesterol often improve on GLP-1 therapy, particularly in patients with metabolic syndrome. Many PlexusDx patients see triglyceride levels drop 20-30% and LDL decline 10-15% even before maximum weight loss occurs. Liver enzymes (ALT, AST) and kidney function (creatinine, eGFR) should remain stable; any upward trend in liver markers warrants discussion with your care team.
Appetite Suppression and Food Behavior Changes on GLP-1 Therapy
The most profound subjective marker on semaglutide or tirzepatide is reduced appetite and altered food preferences. Keep a simple log noting hunger level on a 1-10 scale before meals, portion sizes, and satisfaction after eating. Most patients report hunger dropping to 2-4 on the scale, requiring deliberate effort to eat adequate calories rather than emotional or habitual eating.
Behavioral changes often precede weight loss: skipping snacks you previously couldn't resist, feeling full after half your usual dinner portion, or losing interest in high-sugar foods. These shifts reflect GLP-1 activity in brain regions controlling hunger and reward; documenting them validates that the medication is working even during weeks when weight loss plateaus.
Energy level and cravings intensity also matter clinically. Note whether afternoon energy crashes disappear, whether cravings for specific foods (often refined carbohydrates or sweets) diminish, and whether eating becomes more intentional. The Precision Peptide Genetic Test offered by PlexusDx can reveal your genetic predisposition to certain appetite pathways, helping explain why your response to GLP-1 differs from others.
Setting Realistic Milestones for Tirzepatide and Semaglutide Success
Realistic progress milestones include 1-2 pounds per week on average, with variation based on starting weight, dose level, and adherence. Month 1 often shows 4-8 pounds lost; by month 3, cumulative loss typically reaches 15-25 pounds. These timelines align with clinical trial data and help you distinguish normal progress from concerning stalls.
Plateau periods lasting 2-4 weeks are normal and do not signal treatment failure. Plateaus often precede dose increases or occur as your body adapts; continuing consistent tracking prevents panic and premature dose escalation. PlexusDx medication starts at affordable monthly rates—semaglutide injection at $149/month and tirzepatide injection at $249/month—ensuring cost remains stable as your dose optimizes, with the commitment line: your dose may need to go up, your price won't.
Non-scale victories deserve equal tracking attention: improved blood pressure readings, better sleep quality, reduced joint pain from less weight-bearing stress, and improved mood and mental clarity. Many patients report these changes before reaching their goal weight, making them valid benchmarks of therapeutic success.
How Your Genetics Influence GLP-1 Response
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Tirzepatide Injection starts at $249/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.
Frequently Asked Questions
How often should I weigh myself on semaglutide or tirzepatide?
Weekly weigh-ins provide the clearest trend without daily fluctuation noise. Weigh yourself at the same time each week (ideally morning after using the bathroom, before eating), and plot results on a simple graph or phone app to visualize progress. Daily weigh-ins often cause unnecessary worry from normal hydration and digestive shifts.
What blood tests should I monitor while on GLP-1 therapy?
Request fasting glucose, HbA1c, lipid panel (cholesterol, triglycerides), liver enzymes (ALT, AST), and kidney function (creatinine, eGFR) at baseline and then at 8 weeks, 3 months, and 6 months. These markers show metabolic improvements independent of weight loss and help your provider optimize your semaglutide or tirzepatide dose safely.
How much weight loss should I expect per month on tirzepatide?
Most patients lose 1-2 pounds weekly on average, translating to 4-8 pounds monthly during early treatment phases. By month 3, cumulative loss typically reaches 15-25 pounds.
Is it normal to plateau while on semaglutide or tirzepatide?
Yes, plateau periods of 2-4 weeks are completely normal and do not mean the medication has stopped working. Plateaus often precede dose increases or reflect your body reaching a temporary equilibrium. Continuing your current plan and maintaining detailed tracking helps you push through without unnecessary worry.
Can the Precision Peptide Genetic Test help me predict my GLP-1 response?
PlexusDx's Precision Peptide Genetic Test examines 14 metabolic pathways and 49 peptides tied to appetite, fat storage, and GLP-1 receptor activity—including variants in GLP1R, GIPR, FTO, and MC4R genes.
Related Reading
Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.
Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
Do People Gain Weight on Wegovy? Understanding Weight Management with GLP-1 Medications
Does Compounded Semaglutide Cause Depression? Exploring the Connection